Fast Facts: Measurable Residual Disease: A clearer picture for treatment decisions

By J. Loke

Conventional methods of detecting disease remission in cancers such as leukemia rely on microscopic analysis of tissue samples. Measurable (or minimal) residual disease (MRD) describes the presence of disease beyond the levels of sensitivity afforded by microscopy. Fast Facts: Measurable Residual Disease describes what is meant by MRD, the opportunities and challenges afforded by its identification and the advantages and disadvantages of the methods used for its detection. Specific examples are given to illustrate the implications of detecting MRD in different disease scenarios, with emphasis on acute myeloid and lymphoblastic leukemias. With the recognition and monitoring of MRD likely to play an increasingly important role in disease prognosis and subsequent treatment direction, this accessible resource is ideal for any healthcare professional wanting to know more about this exciting and fast-moving area. Table of Contents: • What is measurable residual disease? • How is MRD measured? • What is the significance of MRD?

• Language: English
• Publisher: S. Karger
• Release date: Jan 26, 2021
• ISBN: 9783318068252

Book preview

Measurable Residual Disease

Declaration of Independence

This book is as balanced and as practical as we can make it.

Ideas for improvement are always welcome: [e-mail]

Fast Facts: Measurable Residual Disease

First published 2020

Text © 2020 Justin Loke

© 2020 in this edition S. Karger Publishers Ltd

S. Karger Publishers Ltd, Elizabeth House, Queen Street, Abingdon, Oxford OX14 3LN, UK

Tel: [phone]

Book orders can be placed by telephone or email, or via the website.

Please telephone [phone] or email [e-mail]

To order via the website, please go to karger.com

Fast Facts is a trademark of S. Karger Publishers Ltd.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the express permission of the publisher.

The rights of Justin Loke to be identified as the author of this work has been asserted in accordance with the Copyright, Designs & Patents Act 1988 Sections 77 and 78.

The publisher and the authors have made every effort to ensure the accuracy of this book, but cannot accept responsibility for any errors or omissions.

For all drugs, please consult the product labeling approved in your country for prescribing information.

Registered names, trademarks, etc. used in this book, even when not marked as such, are not to be considered unprotected by law.

A CIP record for